文献速递儿童感染儿童心血管与肾脏

抗生素预防排尿性膀胱尿道造影相关尿路感染:一项随机对照试验

Antibiotics for performing voiding cystourethrogram: a randomised control trial.
PubMed 文献 · Arch Dis Child · 2017-08-30

这项开放标签随机对照试验在三级儿科肾脏病中心纳入120名2月龄至5岁接受排尿性膀胱尿道造影(VCUG)的儿童,按3:2随机分为抗生素组(n=72)和无抗生素组(n=48)。结果显示无抗生素组VCUG后尿路感染发生率显著高于抗生素组(17% vs 1.4%,p=0.01),且造影前超声异常是独立危险因素。结论认为抗生素可显著减少VCUG后尿路感染,尤其对超声异常者。

要点

  • 无抗生素组VCUG后尿路感染发生率17%,显著高于抗生素组的1.4%(p=0.01)。
  • 造影前超声异常是VCUG后尿路感染的独立危险因素(p=0.02,OR=9.51)。
  • 预防1例VCUG后尿路感染需治疗人数(NNT)为6.5,超声异常亚组为4。

核心结论

  • 抗生素可显著降低VCUG后获得的尿路感染,尤其在造影前超声扫描异常的儿童中。

研究设计与样本

  • 开放标签随机对照试验,在三级儿科肾脏病中心纳入120名2月龄至5岁接受VCUG的儿童。
  • 儿童按3:2随机分为抗生素组(n=72)和无抗生素组(n=48)。
  • 抗生素组在VCUG前一天开始口服抗生素(<6月龄用头孢氨苄,>6月龄用复方磺胺甲噁唑),并持续至VCUG后1天。

主要发现

  • VCUG后尿路感染在无抗生素组显著高于抗生素组(17%(n=8) vs 1.4%(n=1);p=0.01,OR=14.2(95% CI 1.7 to 117))。
  • 多变量二元逻辑回归分析发现造影前超声扫描异常是VCUG后尿路感染的显著独立危险因素(p=0.02,OR=9.51,95% CI 1.43 to 63.4)。
  • 预防1例VCUG后尿路感染需抗生素治疗人数为6.5,仅纳入造影前超声异常组时降至4。

关键数值与推荐

  • 尿路感染定义为有症状儿童尿培养单一菌种显著生长,于VCUG后第3天检查尿液。
  • VCUG指征包括尿路感染病史(婴儿期首次尿路感染=43,复发性尿路感染=49)和无尿路感染的先天性肾脏和尿路异常(n=28)。

临床怎么用

  • 对于接受VCUG的儿童,可考虑预防性使用抗生素以降低VCUG后尿路感染风险。
  • 造影前超声扫描异常的儿童可能从抗生素预防中获益更大。

局限性

  • 开放标签设计可能引入偏倚。
  • 样本量较小(120例),结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether antibiotic reduces voiding cystourethrogram (VCUG)-associated urinary tract infection (UTI). DESIGN: Open-labelled randomised controlled trial. SETTING: Tertiary paediatric nephrology centre. PATIENTS: 120 children (age 2 months-5 years) undergoing VCUG. INTERVENTIONS: Children were randomised into group A (antibiotic, n=72) or group B (no antibiotic, n=48) in 3:2 ratio. Group A received oral antibiotic (cephalexin if <6 months or co-trimoxazole if >6 months old) a day prior to VCUG and continued for 1 day post VCUG. MAIN OUTCOME MEASURES: The main outcome measure is incidence of VCUG-associated UTI. Urine was checked on day 3 after VCUG and UTI was defined as significant growth of a single organism in a symptomatic child. RESULTS: The median age was 8 months (IQR 13 months) with 68% male. Indication for undertaking VCUG was history of UTI (first UTI in infancy=43, recurrent UTI=49) and congenital anomaly of kidney and urinary tract without any UTI (n=28). Post-VCUG UTI was significantly higher among group B in comparison to group A (17% (n=8) vs 1.4% (n=1); p=0.01, OR=14.2 (95% CI 1.7 to 117)). Multivariate binary logistic regression analysis found an abnormal pre-VCUG ultrasound scan to be a significant independent risk factor for post-VCUG UTI (p=0.02, OR=9.51, 95% CI 1.43 to 63.4). The number needed to treat with antibiotic to prevent one post-VCUG UTI was 6.5, which reduced to 4 if only the group with abnormal pre-VCUG ultrasound scan was included. CONCLUSIONS: Antibiotic significantly reduces post-VCUG-acquired UTI especially in those with abnormal ultrasound scans. TRIAL REGISTRATION NUMBER: Clinical Trial Registry of India: CTRI/2017/03/00824.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Sinha R, Saha S, Maji B, et al. Antibiotics for performing voiding cystourethrogram: a randomised control trial. Arch Dis Child. 2017. PMID: 28855226. doi:10.1136/archdischild-2017-313266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。